首页> 美国卫生研究院文献>EXCLI Journal >Cytochrome P450 enzyme mediated herbal drug interactions (Part 1)
【2h】

Cytochrome P450 enzyme mediated herbal drug interactions (Part 1)

机译:细胞色素P450酶介导的中草药相互作用(第1部分)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

It is well recognized that herbal supplements or herbal medicines are now commonly used. As many patients taking prescription medications are concomitantly using herbal supplements, there is considerable risk for adverse herbal drug interactions. Such interactions can enhance the risk for an individual patient, especially with regard to drugs with a narrow therapeutic index such as warfarin, cyclosporine A and digoxin. Herbal drug interactions can alter pharmacokinetic or/and pharmacodynamic properties of administered drugs. The most common pharmacokinetic interactions usually involve either the inhibition or induction of the metabolism of drugs catalyzed by the important enzymes, cytochrome P450 (CYP). The aim of the present article is to provide an updated review of clinically relevant metabolic CYP-mediated drug interactions between selected herbal supplements and prescription drugs. The commonly used herbal supplements selected include Echinacea, Ginkgo biloba, garlic, St. John's wort, goldenseal, and milk thistle. To date, several significant herbal drug interactions have their origins in the alteration of CYP enzyme activity by various phytochemicals. Numerous herbal drug interactions have been reported. Although the significance of many interactions is uncertain but several interactions, especially those with St. John’s wort, may have critical clinical consequences. St. John’s wort is a source of hyperforin, an active ingredient that has a strong affinity for the pregnane xenobiotic receptor (PXR). As a PXR ligand, hyperforin promotes expression of CYP3A4 enzymes in the small intestine and liver. This in turn causes induction of CYP3A4 and can reduce the oral bioavailability of many drugs making them less effective. The available evidence indicates that, at commonly recommended doses, other selected herbs including Echinacea, Ginkgo biloba, garlic, goldenseal and milk thistle do not act as potent or moderate inhibitors or inducers of CYP enzymes. A good knowledge of the mechanisms of herbal drug interactions is necessary for assessing and minimizing clinical risks. These processes help prediction of interactions between herbal supplements and prescription drugs. Healthcare professionals should remain vigilant for potential interactions between herbal supplements/medicines and prescription drugs, especially for drugs with a narrow therapeutic index are used.
机译:众所周知,目前普遍使用草药补品或草药。由于许多服用处方药的患者同时使用草药补充剂,因此草药相互作用不良的风险很大。此类相互作用可能会增加单个患者的风险,尤其是对于治疗指数较窄的药物(如华法林,环孢素A和地高辛)而言。草药相互作用可以改变所给药药物的药代动力学或/和药效学性质。最常见的药代动力学相互作用通常涉及抑制或诱导由重要酶细胞色素P450(CYP)催化的药物代谢。本文的目的是提供有关所选草药补充剂和处方药之间临床相关代谢CYP介导的药物相互作用的最新综述。常用的草药补品包括紫锥花,银杏,大蒜,圣约翰草,白毛,和水飞蓟。迄今为止,几种重要的草药相互作用是通过各种植物化学物质改变CYP酶活性的起源。已经报道了许多草药相互作用。尽管许多相互作用的重要性尚不确定,但几种相互作用,尤其是与圣约翰草的相互作用,可能会产生严重的临床后果。圣约翰草是Hyperforin的来源,Hyperforin是一种对妊娠异种生物受体(PXR)具有强亲和力的有效成分。作为一种PXR配体,hyperforin促进小肠和肝脏中CYP3A4酶的表达。反过来,这会引起CYP3A4的诱导,并可能降低许多药物的口服生物利用度,从而使其作用降低。现有证据表明,在通常推荐的剂量下,其他选定的草药,包括紫锥菊,银杏,大蒜,白毛and和水飞蓟素,均不充当CYP酶的有效抑制剂或中度抑制剂。对草药相互作用的机制有充分的了解对于评估和最小化临床风险是必要的。这些过程有助于预测草药补品和处方药之间的相互作用。医疗保健专业人员应保持警惕,注意草药补充剂/药物与处方药之间的潜在相互作用,尤其是对于使用狭窄治疗指数的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号